VLDL, human

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

DENSITY:

0.95-1.006 g/mL

Product Source: Human plasma tested negative for HBsAg and HIV-I, HIV-II, HBc and Hepatitis C antibodies. All blood products should be treated as potentially infectious.

VLDL is isolated from fresh human plasma containing EDTA and sodium citrate by sequential isopycnic ultracentrifugation at the lower and upper density limits of the specified density range (Havel et al., 1955). Density adjustments are performed with solid KBr. VLDL is washed by centrifugation at the upper density limit to ensure removal of higher density proteins.

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Liquid in 150 mM NaCl, pH 7.4 with 0.01% EDTA. Filtered to sterility using 0.2 micron filter in a sterile vial.

COMPOSITION:

88-95% lipid, 5-12% protein

Maintain at 2-8°C for up to four weeks. DO NOT FREEZE. Freezing may cause denaturation.